)
Agenus (AGEN) investor relations material
Agenus Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Proposal 4 seeks approval for a one-time exchange of underwater stock options held by employees, consultants, and non-employee directors for new options, with executive and director options priced at a 50% premium to fair market value on the exchange date.
The exchange is structured as a one-for-one share replacement, with no increase in the aggregate number of outstanding options.
Approval requires a majority of votes cast by stockholders present in person or by proxy; abstentions and broker non-votes will not affect the outcome.
The Board recommends a vote in favor of Proposal 4.
Executive compensation and say-on-pay
Executives and non-employee directors will receive replacement options with a strike price at 150% of the exchange date’s fair market value, aligning their compensation with future stock price appreciation.
Other employees and consultants will receive options at fair market value, restoring retention and motivation value.
Executives have elected to receive both base and annual bonus compensation entirely in stock and options, with no cash component.
The compensation committee selected this structure to avoid incremental cash outlay and to ensure executives benefit only after significant stock price appreciation.
Board of directors and corporate governance
The compensation committee evaluated alternatives and determined the one-for-one exchange with a premium strike for executives best aligns with stockholder interests.
Executive officers and non-employee directors are eligible to participate if they hold eligible options and remain in service through the exchange date.
- Q1 2026 delivered profitability, global asset expansion, and key regulatory and financial gains.AGEN
Q1 202611 May 2026 - Proxy seeks approval for director elections, equity plan increases, and a one-time option exchange.AGEN
Proxy filing1 May 2026 - Proxy seeks approval for director elections, equity plan amendments, and a one-time option exchange.AGEN
Proxy filing20 Apr 2026 - Strong clinical and commercial momentum positions the company for pivotal regulatory filings in 2026.AGEN
AGM 202631 Mar 2026 - BOT + BAL enters Phase 3 with $4.2M early access revenue and $91M Zydus capital boost.AGEN
Q4 202516 Mar 2026 - Zydus partnership secures manufacturing and capital, driving global access and pivotal trials for BOT/BAL.AGEN
Status update3 Feb 2026 - BOT/BAL data strong, cash up, but partnership losses and going concern risks persist.AGEN
Q2 20242 Feb 2026 - BOT/BAL shows robust efficacy in colorectal cancer, with pivotal trials and regulatory milestones ahead.AGEN
Wells Fargo 2024 Healthcare Conference22 Jan 2026 - BOT/BAL shows strong efficacy in hard-to-treat cancers, with pivotal data and regulatory steps ahead.AGEN
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
Next Agenus earnings date
Next Agenus earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)